Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omniscient Neurotechnology
Sydney, New South Wales, Australiao8t.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Omniscient Neurotechnology has developed Quicktome®, an FDA-cleared AI-driven software that converts standard MRI scans into detailed personalized maps of individual brain networks. The technology supports neurosurgeons with actionable insights for surgical planning and assists researchers in understanding complex neurological diseases. The company’s solutions are commercially deployed globally with a strong presence in the US market (>100 hospitals/clinics), targeting expanded clinical indications including depression, Alzheimer’s disease, schizophrenia, and stroke. Total funding raised exceeds $60 million as of June 2024.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- DeviceNon-pharmacological therapy (AI-driven software platform for brain mapping and analytics)
- Industry
- Medical Imaging
02
Partnerships
Not specifically named; collaborates with top research institutions worldwide and more than 100 US hospitals/clinics.
Beyond the preview
Go deeper on Omniscient Neurotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omniscient Neurotechnology.